Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting
Pathology
.
2022 Feb;54(1):116-120.
doi: 10.1016/j.pathol.2021.10.001.
Epub 2021 Nov 23.
Authors
Hemalatha Varadhan
1
,
Vishal Ahuja
2
,
Catherine Pitman
2
,
Dominic E Dwyer
2
;
NSW Health Pathology
2
Affiliations
1
NSW Health Pathology, NSW, Australia. Electronic address: hemalatha.varadhan@health.nsw.gov.au.
2
NSW Health Pathology, NSW, Australia.
PMID:
34916069
PMCID:
PMC8608624
DOI:
10.1016/j.pathol.2021.10.001
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Molecular Diagnostic Techniques
Nasopharynx
Prevalence
SARS-CoV-2*